CytomX Therapeutics (CTMX) Earnings Date, Estimates & Call Transcripts

$4.08 -0.10 (-2.39%)

Closing price 04:00 PM Eastern

Extended Trading

$4.09 +0.01 (+0.32%)

As of 07:56 PM Eastern

CytomX Therapeutics Earnings Summary

CytomX Therapeutics issued Q4 2025 earnings on March 16, 2026, reporting an EPS of -$0.22, which missed the consensus estimate of -$0.08 by $0.14. Quarterly revenue was reported to be $0.66 million, below analysts' expectations of $7.33 million. With a trailing EPS of -$0.04, CytomX Therapeutics' earnings are expected to decrease next year, from ($0.56) to ($0.67) per share.

Upcoming Earnings Date: May. 7Before Market OpensEstimated
Consensus EPS (Mar. 16): -$0.08
Actual EPS (Mar. 16): -$0.22 Missed By -$0.14
Actual Revenue (Mar. 16): $0.66M

Q4 2025 Earnings Resources

CTMX Upcoming Earnings

CytomX Therapeutics' Q1 2026 earnings is estimated for Thursday, May 7, 2026, based on past reporting schedules, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Q1 2026 Earnings Report

Slide Deck

Full Screen Slide Deck

Get CytomX Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CytomX Therapeutics and other key companies, straight to your inbox.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CTMX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CTMX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CytomX Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2026	2	-$0.15	-$0.14	-$0.15
Q2 2026	2	-$0.18	-$0.13	-$0.16
Q3 2026	2	-$0.18	-$0.14	-$0.16
Q4 2026	2	-$0.19	-$0.14	-$0.17

CytomX Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/7/2026 (Estimated)	-	-	-	-	-	-	-
3/16/2026	Q4 2025	-$0.08	-$0.22	-$0.14	-$0.22	$7.33M	$0.66M
11/6/2025	Q3 2025	-$0.04	-$0.09	-$0.05	-$0.09	$11.50M	$5.96M
5/12/2025	Q1 2025	$0.18	$0.27	+$0.09	$0.27	$35.42M	$50.92M
3/6/2025	Q4 2024	-$0.23	$0.22	+$0.45	$0.22	$13.53M	$38.09M
11/7/2024	Q3 2024	-$0.16	$0.07	+$0.23	$0.07	$18.92M	$33.43M
8/8/2024	Q2 2024	-$0.07	-$0.08	-$0.01	-$0.08	$21.79M	$25.12M
5/8/2024	Q1 2024	-$0.06	$0.17	+$0.23	$0.17	$23.40M	$41.46M

Data powered by Fiscal.ai.

CytomX Therapeutics Earnings - Frequently Asked Questions

: CytomX Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 7th, 2026 based off last year's report dates. Learn more on CTMX's earnings history.
: In the previous quarter, CytomX Therapeutics (NASDAQ:CTMX) missed the analysts' consensus estimate of ($0.08) by $0.14 with a reported earnings per share (EPS) of ($0.22). Learn more on analysts' earnings estimate vs. CTMX's actual earnings.
: The conference call for CytomX Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call
: The conference call transcript for CytomX Therapeutics' latest earnings report can be read online.
Read Transcript
: CytomX Therapeutics (NASDAQ:CTMX) has a recorded annual revenue of $76.20 million.
: CytomX Therapeutics (NASDAQ:CTMX) has a recorded net income of -$17.37 million. CTMX has generated -$0.04 earnings per share over the last four quarters.
: CytomX Therapeutics' earnings are expected to decrease from ($0.56) per share to ($0.67) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies

Earnings Tools

Latest Articles

This page (NASDAQ:CTMX) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CytomX Therapeutics (CTMX) Earnings Date, Estimates & Call Transcripts